Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
1.710
-0.150 (-8.06%)
At close: Dec 5, 2025, 4:00 PM EST
1.661
-0.049 (-2.89%)
After-hours: Dec 5, 2025, 7:31 PM EST
Jasper Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 21.3 | 20.42 | 17.08 | 16.57 | 11.41 | 4.8 | |
| Research & Development | 70.22 | 55.82 | 51.79 | 34.63 | 25.42 | 15.88 | |
| Operating Expenses | 91.52 | 76.24 | 68.86 | 51.2 | 36.83 | 20.68 | |
| Operating Income | -91.52 | -76.24 | -68.86 | -51.2 | -36.83 | -20.68 | |
| Interest & Investment Income | 2.34 | 5.06 | 5.2 | 0.7 | - | - | |
| Other Non Operating Income (Expenses) | -0.03 | -0.09 | -0.82 | 7.09 | -3.08 | -10.99 | |
| EBT Excluding Unusual Items | -89.21 | -71.27 | -64.48 | -43.41 | -39.91 | -31.67 | |
| Other Unusual Items | - | - | 0.02 | 5.73 | 9.28 | - | |
| Pretax Income | -91.02 | -71.27 | -64.47 | -37.69 | -30.64 | -31.67 | |
| Net Income | -91.02 | -71.27 | -64.47 | -37.69 | -30.64 | -31.67 | |
| Net Income to Common | -91.02 | -71.27 | -64.47 | -37.69 | -30.64 | -31.67 | |
| Shares Outstanding (Basic) | 16 | 15 | 10 | 4 | 1 | 0 | |
| Shares Outstanding (Diluted) | 16 | 15 | 10 | 4 | 1 | 0 | |
| Shares Change (YoY) | 15.70% | 39.72% | 186.15% | 220.19% | 558.67% | - | |
| EPS (Basic) | -5.79 | -4.89 | -6.18 | -10.33 | -26.89 | -183.08 | |
| EPS (Diluted) | -5.79 | -4.89 | -6.18 | -10.33 | -26.89 | -183.08 | |
| Free Cash Flow | -76.53 | -63.15 | -52.33 | -46.43 | -36.11 | -18.27 | |
| Free Cash Flow Per Share | -4.87 | -4.33 | -5.01 | -12.73 | -31.69 | -105.60 | |
| EBITDA | -90.51 | -74.87 | -67.75 | -50.22 | -36.46 | - | |
| D&A For EBITDA | 1.01 | 1.37 | 1.11 | 0.98 | 0.38 | - | |
| EBIT | -91.52 | -76.24 | -68.86 | -51.2 | -36.83 | -20.68 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.